Table 1.
Clinical features of patients.
| HIV/HCV co-infection | HCV-infection | p-value | |
|---|---|---|---|
| Age (years) | 34.1±7.4 | 50.2±6.9 | 0.001 |
| Chid-Pugh score | 11.9±1.5 | 11.2±1.4 | 0.332 |
| MELD score | 25.9±10.4 | 19.9±11.1 | 0.230 |
| AST | 80.5±30.2 | 57.7±35.5 | 0.140 |
| ALT | 44.1±15.1 | 37.1±36.8 | 0.589 |
| Protronbin time (INR) | 3.24±2.21 | 1.95±0.56 | 0.087 |
| Albumin | 2.8±0.4 | 2.7±0.3 | 0.540 |
| Prior treatment | 2 patients were treated with interferon | 6 patients were treated with interferon | |
| HCV genotype | 3 patients: 1a; 2 patients: 1b 1 patient: 1a+1b, 1 patient: 2a 1 patient: 2a+2b; 2 patients: 1b+3a |
10 patients: 1b | |
| HCV RNA (log IU/mL) | 5.0±0.7 | 5.1±1.4 | 0.861 |
| HIV load (copy/ml) | 2.7±1.9 | No data | |
| CD4 count (/μl) | 273±231 | No data |
MELD – Model For End-Stage Liver Disease, HCV – hepatitis C virus, HIV – human immunodeficiency virus, INR – international normalized ratio.